BeOne Medicines Ltd. (BEIGF)
OTC
Closed
Oct 8, 2026
Day's Range
21.9552 wk Range
15.95Overview - BEIGF - BeOne Medicines Ltd.
Key Statistics
Valuation
Enterprise Value
29.39B
P/E (Trailing)
‪51.03‬
PEG Ratio
‪0.39‬
Price / Sales (TTM)
‪5.26‬
Price / Book
‪6.23‬
EV / EBITDA
‪27.42‬
Profitability
Gross Margin
‪89.76%‬
Profit Margin
‪10.69%‬
Operating Margin
‪19.06%‬
Return on Assets
‪7.45%‬
Return on Equity
‪14.66%‬
Ownership
Shares Outstanding
1.46B
Float
1.05B
Held by Insiders
‪13.75%‬
Held by Institutions
‪28.69%‬
Price stats
Beta
‪0.51‬
50-Day Avg
‪21.95‬
200-Day Avg
‪23.07‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BEIGF - BeOne Medicines Ltd.
Peers - BEIGF - BeOne Medicines Ltd.
Peer Comparison
Compared with companies in Biotechnology listed on OTC.
- BEIGFOTCBeiGene Ltd.32.27BMarket Cap+27.32%52-week change51.04P/E (Trailing)‪10.69%‬Profit Margin
- ARGNFOTCargenx SE58.55BMarket Cap+10.95%52-week change35.71P/E (Trailing)‪32.26%‬Profit Margin
- AKESFOTCAkeso Inc.12.43BMarket Cap-38.39%52-week change25.67P/E (Trailing)‪-28.03%‬Profit Margin
- AAVXFOTCAbivax SA12.13BMarket Cap+38.06%52-week change-28.78P/E (Trailing)‪0.00%‬Profit Margin
- BCHMYOTCBachem Holding AG7.49BMarket Cap+22.42%52-week change39.58P/E (Trailing)‪21.02%‬Profit Margin
- AKBLFOTCALK-Abelló A/S6.92BMarket Cap+6.61%52-week change33.55P/E (Trailing)‪19.85%‬Profit Margin
- ASLTYOTCAsymchem Laboratories (Tianjin) Co., Ltd. Unsponsored ADR5.89BMarket Cap+60.74%52-week change37.05P/E (Trailing)‪14.60%‬Profit Margin
Profile Summary - BEIGF - BeOne Medicines Ltd.
About
BeiGene Ltd. is a biotechnology company that specializes in the research, development, and commercialization of innovative cancer therapeutics. The company's primary function is to create life-saving drugs that can effectively address the complex nature of cancer treatment, with a strong focus on developing targeted…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
